A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
Post a Comment